Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. May 15, 2025; 17(5): 104737
Published online May 15, 2025. doi: 10.4251/wjgo.v17.i5.104737
Published online May 15, 2025. doi: 10.4251/wjgo.v17.i5.104737
Figure 9 Gene expression of PI3K-AKT signaling pathway in tumor tissues of animals in each group.
A: AKT serine/threonine kinase 1 mRNA expression in the tumor tissues of animals in each group; B: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha mRNA expression in the tumor tissues of animals in each group; C: Relative expression of phosphoinositide-3-kinase regulatory subunit 1 mRNA in the tumor tissues of animals in each group. Compared with the model group, aP < 0.05, bP < 0.01. BXD-L: Banxia Xiexin decoction low dose; BXD-M: Banxia Xiexin decoction medium dose; BXD-H: Banxia Xiexin decoction high dose; PIK3R1: Phosphoinositide-3-kinase regulatory subunit 1; PIK3CA: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha; AKT1: AKT serine/threonine kinase 1.
- Citation: Zu GX, Tang JQ, Huang HL, Han T. Validation and analysis of key factors of Banxia Xiexin decoction against gastric cancer. World J Gastrointest Oncol 2025; 17(5): 104737
- URL: https://www.wjgnet.com/1948-5204/full/v17/i5/104737.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i5.104737